[Diagnosis and parameters for the evaluation of disease activity and prognosis in patients with pulmonary sarcoidosis].
We evaluated the usefulness of serum ACE, BALF lymphocyte%, CD4+/CD8+ ratio when diagnosing pulmonary parenchymal lesion in patients with sarcoidosis. The results showed the substantial usefulness but lesser specificity. Furthermore, we evaluated the values of the above three parameters in terms of the judgment of the disease activity and the reliability for foreseeing the prognosis in BHL sarcoidosis. Elevated serum ACH had a good relationship with the disease activity in both nonsmoker and smoker cases. BALF lymphocyte % also had in smoker cases. But none of three parameters showed a significant relationship with the prognosis in BHL sarcoidosis.
Nagai
S
S
Second Department of Internal Medicine, Kyoto University, Japan.
D000328:Adult; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology; D004796:Clinical Enzyme Tests; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008171:Lung Diseases / Q000175:diagnosis*; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011237:Predictive Value of Tests; D011379:Prognosis; D013902:Radiography, Thoracic; D012507:Sarcoidosis / Q000175:diagnosis*
D007703:Peptidyl-Dipeptidase A